Cargando…

COV-BOOST: evidence to support rapid booster deployment

Detalles Bibliográficos
Autores principales:	Hall, Victoria, Hopkins, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676419/ https://www.ncbi.nlm.nih.gov/pubmed/34922657 http://dx.doi.org/10.1016/S0140-6736(21)02799-9

Ejemplares similares

Protein-based vaccine as the booster dose for adults: evidence and beyond
por: Shang, Lianhan, et al.
Publicado: (2022)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2
por: Vasin, Andrey V, et al.
Publicado: (2023)

Boosters appear effective, but are they always needed?
por: Reddy, K Srinath
Publicado: (2021)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
por: Mina, Michael J, et al.
Publicado: (2021)

Lessons and risks of medical device deployment in a global pandemic
por: Shipley, Rebecca J, et al.
Publicado: (2021)

Boost for the booster
Publicado: (1975)

Learning from the initial deployment of digital contact tracing apps
por: Poletto, Chiara, et al.
Publicado: (2022)

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom
por: Croda, Julio, et al.
Publicado: (2022)

COVID-19 vaccine booster strategy: striving for best practice
por: Tanriover, Mine Durusu, et al.
Publicado: (2022)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Safety of COVID-19 booster dose: is the juice worth the squeeze?
por: Madhi, Shabir A, et al.
Publicado: (2023)

Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022)

COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
por: Hart, John D, et al.
Publicado: (2022)

The double-edged sword effect of expanding Wolbachia deployment in dengue endemic settings
por: Pavan, Márcio G., et al.
Publicado: (2023)

African fictions to boost the scientific culture in Africa
por: Kenmoe, Stephane
Publicado: (2022)

COVID-19 boosters and building trust among UK minority ethnic communities
por: Nellums, Laura B, et al.
Publicado: (2022)

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
por: Sridhar, Saranya, et al.
Publicado: (2022)

KEK: Boosting the booster
Publicado: (1975)

Brookhaven: Booster boost
Publicado: (1986)

Brookhaven: Booster boost
Publicado: (1993)

Plans for EU disease control centre given boost
Publicado: (2013)

Plans for EU disease control centre given boost
Publicado: (2013)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
por: Attolico, Immacolata, et al.
Publicado: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

What a second booster dose of mRNA COVID-19 vaccines tells us
por: Loubet, Paul, et al.
Publicado: (2022)

Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022)

Inactivation of DNA repair—prospects for boosting cancer immune surveillance
por: Truini, Anna, et al.
Publicado: (2018)

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
por: Hung, Ivan F N, et al.
Publicado: (2021)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
por: Feng, Shuo, et al.
Publicado: (2023)

Ten scientific reasons in support of airborne transmission of SARS-CoV-2
por: Greenhalgh, Trisha, et al.
Publicado: (2021)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

Big boost from the Booster
Publicado: (1988)

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
por: Funnell, S. G. P., et al.
Publicado: (2020)

Clinical trials of mTOR inhibitors to boost immunity to viral infection in older adults
por: Dzankic, Paula Juricic, et al.
Publicado: (2021)

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ju6frbhfjuegji2bjq9ovjc1g2